Best Targeted Therapy Hospitals in Vietnam

With advanced oncology infrastructure, Vinmec Hai Phong offers Targeted Therapy for patients with cancers that contain specific treatable molecular alterations. Established in 2018, the JCI accredited hospital is located in Ha noi, Vietnam, and has 200 beds.

Targeted medicines may block signals that allow cancer cells to grow, divide, spread, or develop new blood vessels. The choice of therapy depends on the cancer type, stage, molecular profile, and previous treatments. Comprehensive diagnostic and biomarker testing is performed when appropriate to guide treatment selection.

At Vinmec Ha Long Hospital, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The JCI accredited facility has been functioning since 2018 and is located in Ha noi, Vietnam. The hospital has 500 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

At Vinmec Central Park International Hospital, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 2015, the JCI accredited hospital is located in Ho Chi Minh, Vietnam, and has 178 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.

At Vinmec Phu Quoc Hospital, targeted therapy is offered using state-of-the-art molecular diagnostic instruments and protocols. The JCI accredited facility has been functioning since 2015 and is located in Phu Quoc, Vietnam. The hospital has 150 beds and serves both international and local patients.

Targeted therapy is designed to combat cancer by utilising specific characteristics of tumour molecular structure. Based on the biomarker, targeted drugs could be administered to halt the functioning of proteins or biological pathways responsible for causing cancer. The role of the medical staff involved in the procedure is to determine the treatment plan based on factors such as pathology, molecular diagnostic results, disease stage, and previous treatments.

The state-of-the-art Targeted Therapy services offered by Vinmec Times City, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Ha noi, Vietnam. Founded in 2012, the JCI accredited hospital has 500 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

The state-of-the-art Targeted Therapy services offered by Vinmec Smart City Hospital, using modern precision oncology techniques and internationally recognized treatment protocols, have been operational in Ha noi, Vietnam. Founded in 2020, the JCI accredited hospital has 500 beds and provides cancer care facilities for all its local and overseas patients.

Targeted therapy is medicine developed to target specific molecular changes or proteins that affect the growth and survival of cancer cells. It is applicable only to certain cancers in which a relevant biomarker or genetic alteration is present. Prior to the start of the therapy, doctors may perform tumor profiling or molecular testing to check if the targeted medicine can help the patient.

At Vinmec Da Nang, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 2017, the JCI accredited hospital is located in Da Nang, Vietnam, and has 222 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.

Vinmec Nha Trang aims at providing Targeted Therapy using advanced precision medicine technology and patient-centric oncology care techniques. The JCI accredited hospital was established in 2017 in Nha Trang, Vietnam and has 150 beds to care for both domestic and international patients.

Targeted Therapy is a treatment option that targets specific human DNA and proteins that play a critical role in the growth and survival of cancerous cells. The therapy can be used as a standalone treatment or in combination with chemotherapy, radiotherapy, and other medications, depending on the patient's diagnostic results. Before proceeding with a treatment, medical experts conduct biopsy analyses and molecular tests to identify which treatment is most effective.

At Vinmec Can Tho Hospital, patients can access Targeted Therapy supported by advanced molecular diagnostics and experienced oncology specialists. Established in 2016, the JCI accredited hospital is located in Can Tho, Vietnam, and has 155 beds.

Targeted therapy is a form of precision medicine that focuses on specific features of cancer cells rather than affecting all rapidly dividing cells. Depending on the cancer type and biomarker, treatment may involve targeted medicines administered orally or intravenously. A detailed pathology and molecular assessment helps the oncology team select an appropriate treatment.